AVEO Pharmaceuticals, Inc. (AVEO) stock is lower by -69.59% over the last 12 months, and the average rating from Wall Street analysts is a Moderate Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives AVEO stock a score of 53 out of a possible 100.
That score is chiefly influenced by a fundamental score of 61. In addition to the average rating from Wall Street analysts, AVEO stock has a mean target price of $1.75. This means analysts expect the stock to climb 94.45% over the next 12 months. AVEO’s score also includes a short-term technical score of 58. The long-term technical score for AVEO is 41.
What’s Happening with AVEO Stock Today
AVEO Pharmaceuticals, Inc. (AVEO) stock is higher by 27.03% while the S&P 500 is lower by -0.65% as of 9:48 AM on Tuesday, Sep 10. AVEO has risen $0.19 from the previous closing price of $0.71 on volume of 7,070,896 shares. Over the past year the S&P 500 is up 2.85% while AVEO is lower by -69.59%. AVEO lost -$0.02 per share in the over the last 12 months.